The Committee for Medicinal Products for Veterinary Use (CVMP) agreed that the benefits of Circovac outweigh its risks for the reduction of the lesions in lymphoid tissues which are associated with circovirus infection in piglets and also to help reduce deaths connected with this disease in piglets.